Treatment of pulmonary exacerbations in cystic fibrosis - could do better?

被引：4
|
作者：
Smyth, Alan [1 ]
机构：
[1] Univ Nottingham, Sch Med, Nottingham NG7 2RD, England
来源：
PAEDIATRIC RESPIRATORY REVIEWS | 2016年 / 20卷
关键词：
Cystic fibrosis; Pulmonary exacerbations; Symptom score; Microbiome; Adverse effects of antibiotics; ACUTE-RENAL-FAILURE; TOBRAMYCIN; UK;
D O I：
10.1016/j.prrv.2016.06.004
中图分类号：
R72 [儿科学];
学科分类号：
100202 ;
摘要：
This article describes the nature and significance of pulmonary exacerbations in cystic fibrosis (CF). The effectiveness and safety of current exacerbation treatment are explored. The article concludes with a summary of clinical trials (completed and ongoing) which aim to improve the efficacy and safety of exacerbation treatment. (C) 2016 Elsevier Ltd. All rights reserved.
引用
收藏
页码：6 / 7
页数：2
相关论文
共 50 条
  • [41] Inhaled antibiotics for pulmonary exacerbations in cystic fibrosis
    Smith, Sherie
    Rowbotham, Nicola J.
    Charbek, Edward
    COCHRANE DATABASE OF SYSTEMATIC REVIEWS, 2022, (08):
  • [42] Optimizing outcomes of pulmonary exacerbations in cystic fibrosis
    Szentpetery, Sylvia
    Flume, Patrick A.
    CURRENT OPINION IN PULMONARY MEDICINE, 2018, 24 (06) : 606 - 611
  • [43] Cystic Fibrosis with Asthma-Like Exacerbations ... It Could Be a Fungus
    Petrova, G.
    Papochieva, V.
    Kostova, P.
    Stefanova-Todorova, I.
    Miteva, D.
    Perenovska, P.
    Strateva, T.
    PEDIATRIC PULMONOLOGY, 2021, 56 : S180 - S180
  • [44] Location and Duration of Treatment of Cystic Fibrosis Respiratory Exacerbations Do Not Affect Outcomes
    Collaco, J. Michael
    Green, Deanna M.
    Cutting, Garry R.
    Naughton, Kathleen M.
    Mogayzel, Peter J., Jr.
    AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE, 2010, 182 (09) : 1137 - 1143
  • [45] EFFICACY OF INHALED TOBRAMYCIN IN THE TREATMENT OF PULMONARY EXACERBATIONS IN CHILDREN WITH CYSTIC-FIBROSIS
    STEPHENS, D
    GAREY, N
    ISLES, A
    LEVISON, H
    GOLD, R
    PEDIATRIC INFECTIOUS DISEASE JOURNAL, 1983, 2 (03) : 209 - 211
  • [46] INFLAMMATION, LIPID IMBALANCE AND PEROXIDATION IMPROVE WITH TREATMENT FOR PULMONARY EXACERBATIONS IN CYSTIC FIBROSIS
    Wojewodka, G.
    De Sanctis, J. B.
    Nguyen, D.
    Rousseau, S.
    Berube, J.
    Ahlgren, H. G.
    Gruber, J.
    Landry, J.
    Lands, L. C.
    Bernier, J.
    Matouk, E.
    Radzioch, D.
    PEDIATRIC PULMONOLOGY, 2013, 48 : 282 - 282
  • [47] Use of Dynamic Chest Radiography to Assess Treatment of Pulmonary Exacerbations in Cystic Fibrosis
    FitzMaurice, Thomas Simon
    McCann, Caroline
    Nazareth, Dilip S.
    McNamara, Paul S.
    Walshaw, Martin J.
    RADIOLOGY, 2022, 303 (03) : 675 - 681
  • [48] Changes in pulmonary function with different durations of treatment for acute exacerbations of Cystic Fibrosis
    Nicholson, T. T.
    McKone, E. F.
    Gallagher, C. G.
    IRISH JOURNAL OF MEDICAL SCIENCE, 2010, 179 : S466 - S466
  • [49] Preferred health outcome states following treatment for pulmonary exacerbations of cystic fibrosis
    McLeod, Charlie
    Wood, Jamie
    Mulrennan, Siobhain
    Morey, Sue
    Schultz, Andre
    Messer, Mitch
    Spaapen, Kate
    Wu, Yue
    Mascaro, Steven
    Smyth, Alan R.
    Blyth, Christopher C.
    Webb, Steve
    Snelling, Thomas L.
    Norman, Richard
    JOURNAL OF CYSTIC FIBROSIS, 2022, 21 (04) : 581 - 587
  • [50] Population Pharmacokinetics of Vancomycin Used in the Treatment of Pediatric Cystic Fibrosis Pulmonary Exacerbations
    Stockmann, Chris
    Sherwin, Catherine M. T.
    Zobell, Jeffery T.
    Lubsch, Lisa
    Young, David C.
    Olson, Jared
    Noyes, Blakeslee E.
    Ampofo, Krow
    Spigarelli, Michael G.
    JOURNAL OF PHARMACOKINETICS AND PHARMACODYNAMICS, 2013, 40 : S132 - S132
12345